Products
Integrity / innovation / cooperation / sharing / win-win↔

Products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP4) inh☆ibitor developed by Merck. In October 2006, Sitagliptin phosphate Januvia was approved byλ FDA as the first DPP4 inhibitor for the treatment of t€ype ⅱ diabetes mellitus. The characteristics of this drug are that itα can stimulate insulin secretion while reducing hunger without causing weight gain. H&ypoglycemia and edema will not occur, and it is suitable >for diabetic patients with poor blood glucose control and frequent hypoglycemia.

View details

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech pha rmaceutical enterprise that is market-oriented and realizesα industrial development through R&D innovation and technology ₹transformation.

View details

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is one of t"he most important products for the treatment of arthritis. It is well tolera≥ted and has a low incidence of side effects

View details

Pranlukast

Pranlukast, developed by Ono, is one of the three major leukotriene receptor antagonists. I€n clinical application, it has good therapeutic effect on atεopic asthma and other types of bronchial asthma, and the market prospect is huge. In the ®major category of asthma drugs, leukotriene receptor antagonists have the fastest grow•ing market share.

View details

Avanafil

Chenglian Pharmaceutical is an innovative high-tech pharmaceutic←al enterprise that is market-oriented and realizes industrial deve✔lopment through R&D innovation and technology traβnsformation.

View details

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is the second drug a≈pproved by FDA for Alzheimer's disease in the United States. Its treatment ₽reaches the target dose and has low toxic and side ef✔fects. It has been widely recognized by our medical community, and good toleranc®e is its biggest advantage. In October 1999, Donepezil was launched in China under• the trade name "Aricept", which is the main chemical drug agai&nst Alzheimer's disease. At present, CFDA has approved a number of domestic en↓terprises to produce donepezil preparations, the main dosage forms are tablets, c‌apsules, dispersive tablets, oral disintegrating tablets.

View details

Almotriptan

Migraine medication for adolescents

View details

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Apixaban (Eliquis, Bristol-Myer₽s Squibb/Pfizer), a direct oral factor Xa inhibitor, was ₽approved for use in the 27 EU member states. The world's first drug approved₹ to prevent venous thromboembolism (VTE) in adult patients undergoing ♦elective hip or knee replacement. From June 2019 to June 2020, the annual sales of apixabaπn products overseas reached about $15.4 billion, with a year-on-year →growth of nearly 32%, and the API consumption reached about 23,960 kg, with a year$-on-year growth of about 28%. Compared with its main competitor, Rivaroxaban, the drugπ's annual overseas sales are about $4.5 billion higher.

View details

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise th≥at is market-oriented and realizes industrial development through R&D innovation and techno×logy transformation.

View details
< 12345 > proceed page